Filing Details
- Accession Number:
- 0001209191-23-054632
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-07 18:08:12
- Reporting Period:
- 2023-11-03
- Accepted Time:
- 2023-11-07 18:08:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1534133 | Calcimedica Inc. | CALC | Pharmaceutical Preparations (2834) | 452120079 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1968793 | Sudarshan Hebbar | C/O Calcimedica, Inc. 505 Coast S. Blvd. #202 La Jolla CA 92037 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-03 | 36,000 | $2.74 | 46,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $2.7389, and the range of prices were between $2.645 and $2.80. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.